1,994
Views
28
CrossRef citations to date
0
Altmetric
Research Article

Postpartum maternal codeine therapy and the risk of adverse neonatal outcomes: A retrospective cohort study

, , , , , & show all
Pages 390-395 | Received 12 Mar 2011, Accepted 26 Mar 2012, Published online: 27 Apr 2012

References

  • Kirchheiner J, Schmidt H, Tzvetkov M, Keulen JT, Lotsch J, Roots I, . Pharmacokinetics of codeine and its metabolite morphine in ultra-rapid metabolizers due to CYP2D6 duplication. Pharmacogenomics J 2007; 7:257–265.
  • MacDonald N, Macleod SM. Has the time come to phase out codeine? CMAJ 2010; 182:1825.
  • Ingelman-Sundberg M. Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional diversity. Pharmacogenomics J 2005; 5:6–13.
  • Haiek LN, Kramer MS, Ciampi A, Tirado R. Postpartum weight loss and infant feeding. J Am Board Fam Pract 2001; 14:85–94.
  • Koren G, Cairns J, Chitayat D, Gaedigk A, Leeder SJ. Pharmacogenetics of morphine poisoning in a breastfed neonate of a codeine-prescribed mother. Lancet 2006; 368:704.
  • Madadi P, Koren G, Cairns J, Chitayat D, Gaedigk A, Leeder JS, . Safety of codeine during breastfeeding: fatal morphine poisoning in the breastfed neonate of a mother prescribed codeine. Can Fam Physician 2007; 53:33–35.
  • Bateman DN, Eddleston M, Sandilands E. Codeine and breastfeeding [Letter to the editor]. Lancet 2008; 372:625.
  • Madadi P, Ross CJ, Hayden MR, Carleton BC, Gaedigk A, Leeder JS, . Pharmacogenetics of neonatal opioid toxicity following maternal use of codeine during breastfeeding: a case-control study. Clin Pharmacol Ther 2009; 85:31–35.
  • Willmann S, Edginton AN, Coboeken K, Ahr G, Lippert J. Risk to the breast-fed neonate from codeine treatment to the mother: a quantitative mechanistic modeling study. Clin Pharmacol Ther 2009; 86:634–643.
  • Madadi P, Shirazi F, Walter FG, Koren G. Establishing causality of CNS depression in breastfed infants following maternal codeine use. Paediatr Drugs 2008; 10:399–404.
  • D'Agostino RB, Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998; 17:2265–2281.
  • Urquia ML, Frank JW, Glazier RH, Moineddin R. Birth outcomes by neighbourhood income and recent immigration in Toronto. Health Rep 2007; 18.
  • Urquia ML, Frank JW, Moineddin R, Glazier RH. Immigrants’ duration of residence and adverse birth outcomes: a population-based study. BJOG 2010; 117:591–601.
  • Juurlink DN, Mamdani MM, Lee DS, Kopp A, Austin PC, Laupacis A, . Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. N Engl J Med 2004; 351: 543–551.
  • Juurlink DN, Gomes T, Lipscombe LL, Austin PC, Hux JE, Mamdani MM. Adverse cardiovascular events during treatment with pioglitazone and rosiglitazone: population based cohort study. BMJ 2009; 339:b2942.
  • Park-Wyllie LY, Juurlink DN, Kopp A, Shah BR, Stukel TA, Stumpo C, . Outpatient gatifloxacin therapy and dysglycemia in older adults. N Engl J Med 2006; 354:1352–1361.
  • Rubin DB. Estimating causal effects from large data sets using propensity scores. Ann Intern Med 1997; 127(Pt 2):757–763.
  • Rubin DB, Thomas N. Matching using estimated propensity scores: relating theory to practice. Biometrics 1996; 52:249–264.
  • East N, Dube J, Perrault E. Postpartum pain relief: a randomized comparison of self-administered medication and standard administration. J Obstet Gynaecol Can 2007; 29:975–981.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.